Korro Bio Income Statement (2018-2026) | KRRO

Income Statement Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
9.42M2.27M2.55M1.46M1.09M1.29M
Cost of Revenue (Quarter)
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
17.40M15.66M12.75M13.78M13.27M11.71M3.43M14.69M13.13M14.01M-39.33M13.57M17.14M15.96M16.96M19.74M21.03M13.82M10.98M12.95M
Selling, General & Administrative (Quarter)
9.50M9.33M8.61M9.48M8.00M8.56M-9.24M5.39M5.28M5.14M11.47M7.88M6.99M7.33M8.35M7.83M7.63M6.51M6.19M7.49M
Other Operating Expenses (Quarter)
54.75M34.51M
Operating Expenses (Quarter)
26.90M24.99M21.36M23.26M21.27M20.27M-5.81M20.09M18.41M19.15M26.89M21.45M24.12M23.29M25.31M27.57M28.66M20.33M51.69M20.44M
Operating Income (Quarter)
-17.48M-24.99M-21.36M-23.26M-21.27M-20.27M5.81M-20.09M-18.41M-19.15M-26.89M-21.45M-24.12M-23.29M-23.04M-25.02M-27.20M-19.24M-50.40M-20.44M
EBIT (Quarter)
-17.48M-24.99M-21.36M-23.26M-21.27M-20.27M5.81M-20.09M-18.41M-19.15M-26.89M-21.45M-24.12M-23.29M-23.04M-25.02M-27.20M-19.24M-50.40M-20.44M
Non-operating items
Non Operating Investment Income (Quarter)
-0.01M-0.01M0.00M0.00M
Interest & Investment Income (Quarter)
0.12M0.17M0.08M0.10M0.42M0.35M0.46M0.52M-0.01M0.02M0.59M-0.43M-0.00M-0.07M0.05M0.00M-0.22M
Other Non Operating Income (Quarter)
-0.00M-0.14M-0.03M-0.23M0.62M0.62M0.48M0.79M0.66M1.47M1.91M2.33M2.28M1.94M1.63M1.43M1.18M0.99M0.91M
Net income details
EBT (Quarter)
-17.65M-25.15M-21.50M-23.37M-21.28M-19.57M6.21M-19.61M-17.62M-18.49M-25.43M-19.54M-21.80M-21.01M62.40M-23.39M-25.77M-18.06M68.41M-19.53M
Tax Provisions (Quarter)
0.01M0.00M0.00M0.01M0.00M-0.02M0.02M0.03M0.02M0.03M-0.01M0.10M0.00M-24.49M0.10M
Profit After Tax (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M-21.77M-23.39M-25.77M-18.06M-50.04M-19.83M
Income from Continuing Operations (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M62.30M-23.39M-25.77M-18.06M92.90M-19.62M
Consolidated Net Income (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M62.30M-23.39M-25.77M-18.06M92.90M-19.62M
Income towards Parent Company (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M62.30M-23.39M-25.77M-18.06M92.90M-19.62M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
-17.66M-25.16M-21.50M-23.39M-21.29M-19.55M6.19M-19.61M-17.65M-18.49M-25.43M-19.56M-21.83M-21.00M62.30M-23.39M-25.77M-18.06M92.90M-19.62M
Additional items
EPS (Basic) (Quarter)
-25.78-36.51-31.29-33.59-30.43-27.7324.24-72.20-63.83-25.04-16.63-2.44-2.43-2.266.98-2.49-2.74-1.929.89-1.69
EPS (Diluted) (Quarter)
-27.7324.24-72.20-63.83-25.04-16.63-2.44-2.43-2.266.98-2.49-2.74-1.929.89-1.69
Shares Outstanding (Quarter)
0.68M0.69M0.69M0.70M0.70M0.70M0.26M0.27M0.28M0.74M1.53M8.02M8.99M9.30M8.92M9.38M9.39M9.39M9.40M11.60M
Shares Outstanding (Diluted) (Quarter)
0.70M0.26M0.27M0.28M0.74M1.53M8.02M8.99M9.30M8.92M9.38M9.39M9.39M9.40M11.60M
Shares Outstanding (Entity) (Quarter)
0.69M0.69M0.69M0.70M0.70M0.71M0.26M0.27M0.28M0.74M1.53M
EBITDA (Quarter)
-17.48M-24.99M-21.36M-23.26M-21.27M-20.27M5.81M-20.09M-18.41M-19.15M-26.89M-21.45M-24.12M-23.29M-23.04M-25.02M-27.20M-19.24M-50.40M-20.44M
Interest Expenses (Quarter)
23.99M13.14M0.18M1.28M0.79M1.06M-0.45M0.28M0.00M0.00M0.10M0.20M69.68M71.87M0.10M0.20M36.71M42.06M0.10M22.71M
Tax Rate (Quarter)
-0.06%-0.01%-0.01%-0.05%-0.01%0.12%0.31%-0.15%-0.09%-0.14%0.04%0.17%0.00%-35.80%-0.49%